Senior insider sale
Chief Financial Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$957.8K
12K shares
What this filing means
HENDERSON JANE plans to sell 12K shares of APOGEE THERAPEUTICS, INC. valued at approximately $957.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001950047-26-003927
Officer· Chief Financial Officer
Since Mar 2026
12K
Shares to sell
$957.8K
Approx. market value
2K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Award
N/A
2/1/2023
2KTotal acquired2K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2023 | Restricted Stock Award N/A | 2K | — |
| Total | 2K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
2K
Market value
$180.0K
4/16/2026
—Completed
Units to sell
2K
Market value
$170.0K
4/1/2026
—Completed
Units to sell
2K
Market value
$170.0K
3/25/2026
—Completed
Units to sell
2K
Market value
$140.4K
3/2/2026
—Completed
Units to sell
2K
Market value
$131.6K
2/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2K
Market value
$165.8K
5/1/2026
Total
Units
12K
Value
$957.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 2K | $180.0K | — | Completed |
4/1/2026 | 2K | $170.0K | — | Completed |
3/25/2026 | 2K | $170.0K | — | Completed |
3/2/2026 | 2K | $140.4K | — | Completed |
2/2/2026 | 2K | $131.6K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 2K | $165.8K | NASDAQ | Planned |
| Total | 12K | $957.8K | ||